REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Boehringer Ingelheim, Spol. S R.O. (Czech Republic)

Main Activities: Pharmaceutical and Medicine Manufacturing | Other Chemical and Allied Products Merchant Wholesalers
Full name: Boehringer Ingelheim, Spol. S R.O. Profile Updated: March 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Boehringer Ingelheim is a pharmaceutical company which is focused on research and development of innovative medicines. The company has been established in Germany in 1885 and nowadays belongs into 20 most important pharmaceutical companies in the world and is a leader in the field of biopharmacy and biomanufacturing.

Headquarters
Purkynova 2121/3
Prague; The City of Prague; Postal Code: 11000

Contact Details: Purchase the Boehringer Ingelheim, Spol. S R.O. report to view the information.

Website: http://www.boehringer-ingelheim.cz

Basic Information
Total Employees:
Purchase the Boehringer Ingelheim, Spol. S R.O. report to view the information.
Outstanding Shares:
Purchase the Boehringer Ingelheim, Spol. S R.O. report to view the information.
Registered Capital:
Purchase the Boehringer Ingelheim, Spol. S R.O. report to view the information.
Financial Auditors:
Purchase the Boehringer Ingelheim, Spol. S R.O. report to view the information.
Incorporation Date:
October 30, 1992
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Proxy
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Boehringer Ingelheim, Spol. S R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
9.14%▲
Total operating revenue
9.69%▲
Operating profit (EBIT)
11.09%▲
EBITDA
32.66%▲
Net Profit (Loss) for the Period
-11.1%▼
Total assets
-5.23%▼
Total equity
-5.13%▼
Operating Profit Margin (ROS)
0.05%▲
Net Profit Margin
-0.42%▼
Return on Equity (ROE)
-2.9%▼
Quick Ratio
0.1%▲

Similar companies

Zentiva K.S.
 
Novartis S.R.O.
Teva Czech Industries S.R.O.
 
Hartmann - Rico A.S.
Roche S.R.O.
 
Lohmann & Rauscher S.R.O.
Janssen-Cilag S.R.O.
 
Ferring-Leciva A.S.
Glenmark Pharmaceuticals S.R.O.
 
Bioveta A.S.
Walmark A.S.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo